albuterol has been researched along with Chronic Kidney Diseases in 1 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hogas, S | 1 |
| Ardeleanu, S | 1 |
| Segall, L | 1 |
| Serban, DN | 1 |
| Serban, IL | 1 |
| Hogas, M | 1 |
| Apetrii, M | 1 |
| Onofriescu, M | 1 |
| Sascau, R | 1 |
| Covic, A | 1 |
1 other study available for albuterol and Chronic Kidney Diseases
| Article | Year |
|---|---|
Changes in arterial stiffness following dialysis in relation to overhydration and to endothelial function.
Topics: Adrenergic beta-2 Receptor Agonists; Adult; Aged; Albuterol; Analysis of Variance; Blood Flow Veloci | 2012 |